Tokyo, Japan

Tsutomu Komazawa

This inventor holds 1 USPTO granted patent. Top assignee: Nisshin Flour Milling Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsutomu Komazawa. Retrieved from https://idiyas.com/inventor/tsutomu-komazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tsutomu Komazawa: Innovator in Antiarteriosclerosis Treatment

Introduction

Tsutomu Komazawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperlipemia. His innovative work has led to the development of a unique method that utilizes isoquinolinone derivatives.

Latest Patents

Komazawa holds a patent for a method for treating hyperlipemia. This patent focuses on the use of isoquinolinone derivatives as an antiarteriosclerosis agent and antihyperlipoproteinemics. The derivatives are characterized by a specific formula wherein R₁ is hydrogen or a C₁-C₆ alkyl group, and R₂ is a C₁-C₆ alkyl group or a pharmaceutically acceptable salt thereof. He has 1 patent to his name.

Career Highlights

Tsutomu Komazawa is associated with Nisshin Flour Milling Co., Ltd., where he has been able to apply his expertise in pharmaceutical innovations. His work has been instrumental in advancing treatments for cardiovascular conditions.

Collaborations

Some of his notable coworkers include Isao Takahasi and Motoharu Hasegawa. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Tsutomu Komazawa's contributions to the field of pharmaceuticals, particularly in the treatment of hyperlipemia, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…